Pain Management

Diclofenac sodium topical gel was first approved by the FDA in 2007 as a prescription drug, and was indicated for the relief of osteoarthritis pain in joints responsive to topical treatment, particularly the joints of the hands, knees, and feet.

To streamline the way opioid treatments are administered and to successfully treat addicts, a pharmacist’s clinical expertise is maximized in a medication-assisted treatment setting within opioid treatment programs.

Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, explains key facts pharmacists should know about cannabidiol products and pain management.

Published in the Journal of the American Medical Association, the study was conducted using a segmented regression analysis of an interrupted time series over a course of 30 months.

Hydromorphone prescription rates may explain the recent increase in cases of infective endocarditis among people who inject drugs.

The action marks the first and only OTC topical drug with cannabidiol to receive certification for its listing in the National Drug Code Directory, according to its manufacturer.

Specialty pharmacists are well positioned to manage the opioid epidemic because they are in regular contact with their patients who trust them.

Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, discusses best uses for opioids, and when to use other pain medications.

Shared decision making is a tool used by health care professionals to educate more thoroughly, and communicate with their patients.

The statement pointed out that the spread of legalized marijuana products has increased the need for unified labeling requirements.

Danny Sanchez, vice president and general manager, Population Health Services for Omnicell, explains how technology can be used to monitor patients on opioids and intervene before an overdose. This video was filmed at the ASHP (American Society of Health-System Pharmacists) Midyear Clinical Meeting & Exhibition in Las Vegas.

Ubrogepant is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved by the agency for the acute treatment of migraine.

Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, CEO of Remitigate, discusses how opioid and pain management guidelines have evolved. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.

A Multimodal Analgesic Approach Can Improve the Quality of Analgesia and Reduce Adverse Effects.

"Opioids are associated with significant side effects in some patients, side effects that can frequently be managed by ancillary therapies."

The FDA has previously sent warning letters to other companies for illegally selling CBD products that had claimed to prevent, diagnose, mitigate, treat, or cure serious diseases, such as cancer.

These health care professionals should receive education on how to prevent opioid misuse.

As approved delegates, techs can assist pharmacists by reviewing prescription drug monitoring programs.

Why is this woman in opioid withdrawal despite high dose methadone administration?

The online resource features CBD products that have been tested for concentrations of all cannabinoids, including CBD and tetrahydrocannabinol (THC), by an independent, third-party lab, as well as experts that pharmacists can contact with questions regarding buying, selling, and marketing.

Jesica Mills, PharmD, MBA, discusses the opportunities pharmacists have to help their patients with hemp-derived CBD products. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Four pharmaceutical distributors have agreed to settle federal litigation related to the ongoing opioid epidemic for a collective $260 million, less than a day before a federal trial was set to begin in Ohio.

A new Health Trends study released by Quest Diagnostics has highlighted many physicians' overconfidence in their ability to identify and treat substance misuse, as well as concerns that the drug gabapentin is increasingly being misused.

The agency's move opens the door to more versions of the neuropathic pain reliever.

Johnson & Johnson and its Janssen Pharmaceutical Cos unit have agreed to a more than $10 million settlement, rather than allowing the matter go to federal trial.

OTC case studies for headache treatment during pregnancy and lower-back pain remedies.

Pharmacists can help patients by recommending the most effective and safest therapies.

All 3 are essential in the fight against the opioid crisis, but they need to forge alliances and work together.

Analgesic Alternatives May Help Reduce Unnecessary Exposure to Opioid Medications

Calcitonin gene-related peptide inhibitors are integral to preventing these powerful headaches.